• HitGen Announces Collaboration in Drug Discovery with the University of Manchester’s Cancer Research UK Manchester Institute and Cancer Research Technology

    Partnership will use HitGen’s DNA Encoded Library Technology for Drug Lead Identification

    HitGen Announces Collaboration in Drug Discovery with the University of Manchester’s Cancer Research UK Manchester Institute and Cancer Research Technology
     
  • HitGen and Viva Biotech Establish Strategic Alliance

    HitGen and Viva Biotech announce a strategic alliance. The two companies will collaborate to provide a fully-integrated drug discovery services, with partnership focus on early hit to lead generation, to accelerate their clients’ drug discovery projects from targets into early development.

    HitGen and Viva Biotech Establish Strategic Alliance
     
  • HitGen: aspiring technologies

    HitGen is your partner at the forefront of early stage drug discovery. Utilising advanced compound library design, synthesis and screening technologies, we provide a platform for progressing projects from targets to leads.

     

    HitGen: aspiring technologies
     
  • HitGen: inspiring discoveries

    Using our powerful platform, we provide our partners services which focus on quality, speed and efficiency, delivering value for money. Our products and services include Targets to Hit/Leads, Hits/Leads Expansion, as well as progressing selected programmes to pre-clinical and early clinical stages. We can also apply our capabilities to support partner research programmes.

    HitGen: inspiring discoveries
     
HitGen: advancing innovative drug discoveries

Target to Hits/Leads

Custom compound libraries

Collaborative Drug Discovery Programmes with Partners

Research Support


HitGen is a life science company with a focus on hit identification and lead generation. Our core capabilities include medicinal chemistry, computational chemistry, high speed synthesis, cell and molecular biology, in vitro screening and selection. Our core assets are large, diverse and high quality encoded chemical libraries.

We provide products and services to our partners which enable them to progress targets to hits/leads, and eventually to pre-clinical and early clinical stages.

 

Link:
logo